Attachment 8
Contact Information for Consultants
Ms. Sandra Berry, MA Senior Behavioral Scientist RAND Corporation 1700 Main Street Santa Monica, CA 90407-2138 (310) 393-0411 X7051 berry@rand.org
Dr. Sam Bozzette, MD, PhD Senior Natural Scientist RAND Corporation 1776 Main St., m5s Santa Monica, CA 90407 (310) 393-0411 bozzette@smmail1.rand.org
Dr. Marty Frankel, PhD Statistician RAND Corporation 14 Patricia Lane Cos Cob, CT 06807 (203) 869-1324 Martin_Frankel@abtassoc.com
Dr. Martin Shapiro, MD, PhD Researcher RAND Corporation 911 Broxton Ave LA, CA 90024 (310) 393-0411 mfshapiro@mednet.ucla.edu |
Dr. Alice Kroliczak, PhD Supervisory Health Scientist Health Resources and Services Administration Division of Science and Policy, HAB 5600 Fishers Lane, #7-90 Rockville, MD 20857 (301) 443-3592
Ms. Faye Malitz, MS Chief, Epidemiology and Data Branch Health Resources and Services Administration Division of Science and Policy, HAB 5600 Fishers Lane, #7-90 Rockville, MD 20857 (301) 443-3259
Dr. Richard Conviser, PhD Health Scientist Health Resources and Services Administration Division of Science and Policy, HAB 5600 Fishers Lane, #7-90 Rockville, MD 20857 301-443-3075
Dr. Laura Cheever, MD Deputy Associate Administrator Health Resources and Services Administration Division of Science and Policy, HAB 5600 Fishers Lane, #7-90 Rockville, MD 20857 301-443-3067
|
Dr. Robert Mills, PhD Health Statistician Health Resources and Services Administration Division of Science and Policy, HAB 5600 Fishers Lane, #7-90 Rockville, MD 20857 301-443-3899 RMills@hrsa.gov |
Dr. Victoria Cargill, MD Director, Minority Research National Institutes of Health Office of AIDS Research 5635 Fishers Lane 4th Floor Rockville, MD 20857 (301) 402-2932 CargillV@OD.NIH.GOV |
Drs. Bozzette, Frankel, Shapiro and Ms. Berry participated in the following consultations: in September, 2003 to discuss sampling methods and lessons learned from previous projects; in November, 2003 to commence planning, identify sampling approaches and design for clinical outcomes surveillance; in March 2004 to discuss Medical Monitoring Project domains; in October 2004 to discuss second and third stage sampling, review project progress and discuss sampling issues, stratification parameters, and review scientific quality issues; and in September 2005 to discuss patient sampling methods and tasks. They have also participated in bi-weekly conference calls from 2004 to the present.
Drs. Kroliczak, Mills, Cheever, Conviser, Bozzette and Ms. Malitz participated in a consultation in November 2004 to discuss how to use MMP data to meet HRSA data needs, how to avoid redundancy in data collections by CDC and HRSA grantees, and discuss research questions of interest to HRSA. Also discussed future collaborations between CDC and HRSA on the MMP. Dr. Cargill has been consulted as needed since 2004.
The MMP Provider Survey was discussed with the MMP Provider Advisory Board, Community Advisory Board, Principal Investigators and Project Coordinators at the MMP National Advisory Meeting that took place in Atlanta, Georgia in October 2007.
No major problems arose that could not be resolved during these consultation.
| File Type | application/msword |
| File Title | Attachment 8 |
| Author | aom5 |
| Last Modified By | ziy6 |
| File Modified | 2009-02-26 |
| File Created | 2009-02-26 |